| Literature DB >> 32745458 |
Wassim W Labaki1, Sharon R Rosenberg2.
Abstract
Chronic obstructive pulmonary disease (COPD) is characterized by persistent respiratory symptoms and progressive airflow obstruction. Tobacco smoking is the leading cause but not the only one. A postbronchodilator FEV1-FVC ratio less than 0.70 is required for a diagnosis of COPD. Inhaler therapy is the backbone of treatment and should be complemented by a multifaceted management strategy that includes counseling and pharmacotherapy for smoking cessation, pulmonary rehabilitation, treatment of comorbidities, administration of influenza and pneumococcal immunizations, and prescription of long-term oxygen therapy in hypoxemic patients.Entities:
Mesh:
Substances:
Year: 2020 PMID: 32745458 DOI: 10.7326/AITC202008040
Source DB: PubMed Journal: Ann Intern Med ISSN: 0003-4819 Impact factor: 25.391